Produkt-Name |
9-Fluor-11β,17,21-trihydroxy-16α-methylpregna-1,4-dien-3,20-dion 17,21-di(propionat) |
Synonyme |
Dexamethasondipropionat [USAN]; Dexamethasondipropionat; 9-Fluor-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-dien-3,20-dion 17,21-dipropionat; Dexamethason-17,21-dipropionat; Methaderm; ST12; THS-101; UNII-K3UKR54YXW; 9-Fluor-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-dien-3,20-dion 17,21-di(propionat); Pregna-1,4-dien-3,20-dion, 9-Fluor-11-beta,17,21-trihydroxy-16-alpha-methyl-, 17,21-dipropionat; Pregna-1,4-dien-3,20-dion, 9-Fluor-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16alpha)-; (11beta,16alpha)-9-fluor-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17,21-diyldipropanoat |
Englischer Name |
9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate);Dexamethasone dipropionate [USAN]; Dexamethasone dipropionate; 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate; Dexamethasone 17,21-dipropionate; Methaderm; ST12; THS-101; UNII-K3UKR54YXW; 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate); Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 17,21-dipropionate; Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16alpha)-; (11beta,16alpha)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate |
Molekulare Formel |
C28H37FO7 |
Molecular Weight |
504.5876 |
InChI |
InChI=1/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19+,20+,21+,25+,26+,27+,28+/m1/s1 |
CAS Registry Number |
55541-30-5 |
EINECS |
259-699-8 |
Molecular Structure |
|
Dichte |
1.24g/cm3 |
Siedepunkt |
603.2°C at 760 mmHg |
Brechungsindex |
1.549 |
Flammpunkt |
318.6°C |
Dampfdruck |
4.58E-17mmHg at 25°C |
Gefahrensymbole |
|
Risk Codes |
|
Safety Beschreibung |
|
|